NCT03713138View on ClinicalTrials.gov

Therapeutic Role of Flax Seed for Poly Cystic Ovary Syndrome

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

March 23, 2017

Primary Completion Date

January 1, 2018

Study Completion Date

January 1, 2018

Conditions

Poly Cystic Ovary Syndrome

Interventions

DIETARY_SUPPLEMENT

flaxseed powder

Three different quantities of flax seed powder were intervened to the subjects. One group was given 15 grams of flax seed a day. Second group was given 20 grams and third group was given 25 grams off lax seed a day.

Trial Locations (1)

45710

Allama Iqbal Open University, Islamabad

All Listed Sponsors

lead

Allied Hospital Faisalabad

OTHER

NCT03713138 - Therapeutic Role of Flax Seed for Poly Cystic Ovary Syndrome | Biotech Hunter | Biotech Hunter